SAT0219 Upadacitinib in patients with active rheumatoid arthritis and inadequate response or intolerance to biological dmards: a phase 3 randomized, placebo-controlled, double-blind study of a selective jak1 inhibitor

Mapping Intimacies ◽

10.1136/annrheumdis-2018-eular.4180 ◽

2018 ◽

Author(s):

M. C. Genovese ◽

R. Fleischmann ◽

B. Combe ◽

S. Hall ◽

Y. Zhang ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Double Blind Study ◽

Inadequate Response ◽

Phase 3 ◽

Double Blind ◽

Biological Dmards

Download Full-text

OP0035 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

10.1136/annrheumdis-2018-eular.4237 ◽

2018 ◽

Cited By ~ 3

Author(s):

J. Smolen ◽

S. Cohen ◽

P. Emery ◽

W. Rigby ◽

Y. Tanaka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Double Blind Study ◽

Inadequate Response ◽

Phase 3 ◽

Double Blind ◽

Randomised Controlled

Download Full-text

OP0036 A phase 3 randomised, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective jak-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards

10.1136/annrheumdis-2018-eular.3131 ◽

2018 ◽

Author(s):

G. Burmester ◽

J. Kremer ◽

F. van den Bosch ◽

Y. Li ◽

Y. Zhou ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Double Blind Study ◽

Inadequate Response ◽

Phase 3 ◽

Double Blind ◽

Synthetic Dmards

Download Full-text

060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

Rheumatology ◽

10.1093/rheumatology/kez106.059 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Cited By ~ 1

Author(s):

J S Smolen ◽

S Cohen ◽

P Emery ◽

W Rigby ◽

Y Tanaka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Double Blind Study ◽

Inadequate Response ◽

Phase 3 ◽

Double Blind ◽

Randomised Controlled

Download Full-text

242 A phase III randomised placebo-controlled double-blind study of upadacitinib (ABT-494), a selective JAK-1 Inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic DMARDs

Rheumatology ◽

10.1093/rheumatology/key075.466 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Cited By ~ 1

Author(s):

Gerd R Burmester ◽

Joel Kremer ◽

Filip van den Bosch ◽

Yihan Li ◽

Yijie Zhou ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Inadequate Response ◽

Double Blind ◽

Synthetic Dmards

Download Full-text

SAT0257 A phase 2b/3 randomised, placebo-controlled, double-blind study of upadacitinib, a selective jak1 inhibitor, in japanese patients with active rheumatoid arthritis and inadequate response to conventional synthetic dmards

10.1136/annrheumdis-2018-eular.4302 ◽

2018 ◽

Cited By ~ 2

Author(s):

Y. Tanaka ◽

T. Takeuchi ◽

K. Yamaoka ◽

M. Oribe ◽

M. Kawano ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Inadequate Response ◽

Double Blind ◽

Synthetic Dmards

Download Full-text

AB0438 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis WHO HAD an Inadequate Response to Tnf-Alpha Inhibitors: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.3305 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 952.3-953

Author(s):

M. Schiff ◽

B. Combe ◽

T. Dörner ◽

J.M. Kremer ◽

T.W. Huizinga ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

B Cell ◽

Tnf Alpha ◽

Double Blind Study ◽

Inadequate Response ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

B Cell Activating Factor

Download Full-text

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

The Lancet ◽

10.1016/s0140-6736(19)30419-2 ◽

2019 ◽

Vol 393 (10188) ◽

pp. 2303-2311 ◽

Cited By ~ 59

Author(s):

Josef S Smolen ◽

Aileen L Pangan ◽

Paul Emery ◽

William Rigby ◽

Yoshiya Tanaka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Double Blind

Download Full-text

FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis Who HAD an Inadequate Response to Methotrexate Therapy: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.1535 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 504.2-504

Author(s):

J.S. Smolen ◽

M.E. Weinblatt ◽

D. van der Heijde ◽

W.F. Rigby ◽

R. van Vollenhoven ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

B Cell ◽

Methotrexate Therapy ◽

Double Blind Study ◽

Inadequate Response ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

B Cell Activating Factor

Download Full-text

FRI0154 SAFETY AND EFFICACY OF FILGOTINIB IN PATIENTS AGED 65 YEARS AND OLDER: RESULTS FROM A PHASE 3 STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR)

10.1136/annrheumdis-2019-eular.2121 ◽

2019 ◽

Author(s):

Kenneth Kalunian ◽

Jacques-Eric Gottenberg ◽

Mark C. Genovese ◽

Neelufar Mozaffarian ◽

Beatrix Bartok ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Safety And Efficacy ◽

Biological Dmards

Download Full-text

OP0226 Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept in Patients with Active Rheumatoid Arthritis (RA) despite Methotrexate (MTX) Therapy

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1800 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 143.1-143 ◽

Cited By ~ 3

Author(s):

J. O'Dell ◽

T. Takeuchi ◽

Y. Tanaka ◽

I. Louw ◽

T. Tiabut ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Blind Study ◽

Double Blind Study ◽

Double Blind

Download Full-text